ExodusPoint Capital Management, LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$34
-100.0%
75,792
+41.6%
0.00%
-100.0%
Q3 2022$92,000
-58.7%
53,544
-14.0%
0.00%
-66.7%
Q1 2022$223,000
-53.2%
62,248
-34.8%
0.00%
-40.0%
Q4 2021$476,000
-25.0%
95,448
+39.3%
0.01%
-28.6%
Q2 2021$635,000
+118.2%
68,532
+118.3%
0.01%
+75.0%
Q1 2021$291,000
+8.6%
31,400
+3.8%
0.00%
+33.3%
Q4 2020$268,00030,2520.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders